UA31754A - METHOD OF PREVENTION OF RECURRENCES OF SKIN MELANOMA - Google Patents

METHOD OF PREVENTION OF RECURRENCES OF SKIN MELANOMA

Info

Publication number
UA31754A
UA31754A UA98105681A UA98105681A UA31754A UA 31754 A UA31754 A UA 31754A UA 98105681 A UA98105681 A UA 98105681A UA 98105681 A UA98105681 A UA 98105681A UA 31754 A UA31754 A UA 31754A
Authority
UA
Ukraine
Prior art keywords
recurrences
prevention
skin melanoma
melanoma
skin
Prior art date
Application number
UA98105681A
Other languages
Ukrainian (uk)
Inventor
Ігор Йосипович Галайчук
Игорь Иосифович Галайчук
Original Assignee
Тернопільська Державна Медична Академія І.Я.Горбачевського
Тернопольская государственная медицинская академия имени И.Я.Горбачевского
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тернопільська Державна Медична Академія І.Я.Горбачевського, Тернопольская государственная медицинская академия имени И.Я.Горбачевского filed Critical Тернопільська Державна Медична Академія І.Я.Горбачевського
Priority to UA98105681A priority Critical patent/UA31754A/en
Publication of UA31754A publication Critical patent/UA31754A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід відноситься до медицини, зокрема, до онкології, й може бути використаним при комбінованому лікуванні меланоми шкіри. Спосіб профілактики рецидивів меланоми включає внутрішньовенне введення Дакарбазину. Його здійснюють з одночасною аплікацією порошку Дакарбазину на ділянку операційної рани.The invention relates to medicine, in particular to oncology, and can be used in the combined treatment of skin melanoma. A method of preventing recurrence of melanoma includes intravenous administration of dacarbazine. It is performed with simultaneous application of Dakarbazin powder to the area of the surgical wound.

UA98105681A 1998-10-28 1998-10-28 METHOD OF PREVENTION OF RECURRENCES OF SKIN MELANOMA UA31754A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA98105681A UA31754A (en) 1998-10-28 1998-10-28 METHOD OF PREVENTION OF RECURRENCES OF SKIN MELANOMA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA98105681A UA31754A (en) 1998-10-28 1998-10-28 METHOD OF PREVENTION OF RECURRENCES OF SKIN MELANOMA

Publications (1)

Publication Number Publication Date
UA31754A true UA31754A (en) 2000-12-15

Family

ID=74283757

Family Applications (1)

Application Number Title Priority Date Filing Date
UA98105681A UA31754A (en) 1998-10-28 1998-10-28 METHOD OF PREVENTION OF RECURRENCES OF SKIN MELANOMA

Country Status (1)

Country Link
UA (1) UA31754A (en)

Similar Documents

Publication Publication Date Title
DK1032376T3 (en) Use of benzhydrylsulfinyl derivatives for the treatment of sleepiness of medicinal origin
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
MY132705A (en) Novel compounds with analgesic effect
ID21863A (en) COMPOUNDS OF KINOLIN AND KINAZOLIN USED IN THERAPY, SPECIFICALLY IN TREATMENT OF TYPICAL PROSTATIC HEPERPLASIA
GEP20002012B (en) External Antiinflammatory Agent
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
TR200103819T2 (en) ET743 compositions and uses in cancer treatment
HK1045524A1 (en) 5-Hydroxysapogenin derivatives with anti-dementia activity
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
FI973185A (en) Use of melatonin in the treatment of patients with drug dependence
UA31754A (en) METHOD OF PREVENTION OF RECURRENCES OF SKIN MELANOMA
GB2347625A (en) Agent for treating allergic or hypersensivity condition
HUP0204208A2 (en) Antipruritic agents for external use
PL334093A1 (en) Application of comt inhibitors in production of drugs preventing occurence of vascular disorders in case of diabetes
SE9800139D0 (en) New use
DE60130253D1 (en) COMPOSITIONS FOR PREVENTING ADHESION
DE60120159D1 (en) SKIN CARE PRODUCTS
NO20032799L (en) New therapeutic applications of thienylcyclohexylamine derivatives
RU94024337A (en) Antimetastatic agent
WO1999003509A3 (en) Pharmaceutical products containing triiodoaromats containing perfluoroalkyl groups, and the use thereof in the treatment of tumours and interventional radiology
NO991047D0 (en) Transdermal therapeutic approach involving a combination of active substances containing ° striol
DE10390700D2 (en) Capsule for the time-delayed administration of nutrients and / or active ingredients
DE69428276T2 (en) INSULIN-LIKE GROWTH FACTOR II AS AN ANTITUARY AGENT
ITFI920241A1 (en) USE OF MELATONIN IN SYSTEMIC SCLEROSIS THERAPY, SARCOIDOSIS AND OTHER